Androgens in human breast carcinoma

Takashi Suzuki, Yasuhiro Miki, Kiyoshi Takagi, Hisashi Hirakawa, Takuya Moriya, Noriaki Ohuchi, Hironobu Sasano

研究成果: Article査読

34 被引用数 (Scopus)

抄録

Sex steroids play important roles in the development of human breast carcinoma. Androgen receptor (AR) is expressed in a majority of breast carcinoma tissues. However, the significance of androgen actions remains largely unclear in breast carcinoma, differing from estrogen actions. Therefore, in this review, we summarized recent studies on androgens in breast carcinoma. Concentration of a potent androgen, 5α-dihydrotestosterone (DHT), was significantly higher in breast carcinoma tissue than in plasma, and DHT is considered to be locally produced from circulating androstenedione by 17β-hydroxysteroid dehydrogenase type 5 and 5α-reductase. On the other hand, aromatase was recently reported as a negative regulator for intratumoral DHT production by possibly reducing the precursor testosterone. Androgens predominantly show antiproliferative effects in breast carcinoma cells, but association between AR status and the clinical outcome of the patient remains controversial, perhaps partly because AR status does not necessarily reflect androgenic action in breast carcinoma. Recently, molecular apocrine breast carcinoma was identified by microarray analysis. Molecular apocrine carcinoma was characterized by being estrogen receptor (ER) negative and AR positive and by being associated with increased androgen signaling and apocrine features. Therefore, androgenic actions may also be involved in apocrine features in breast carcinoma.

本文言語English
ページ(範囲)75-81
ページ数7
ジャーナルMedical Molecular Morphology
43
2
DOI
出版ステータスPublished - 2010 6

ASJC Scopus subject areas

  • 病理学および法医学
  • 分子生物学

フィンガープリント

「Androgens in human breast carcinoma」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル